News:

This week IPhone 15 Pro winner is karn
You can be too a winner! Become the top poster of the week and win valuable prizes.  More details are You are not allowed to view links. Register or Login 

Main Menu

Roche bans rivals from comparing copycat drugs to Herceptin

Started by riky, February 08, 2014, 09:00:21 AM

Previous topic - Next topic

0 Members and 1 Guest are viewing this topic.

riky

Roche bans rivals from comparing copycat drugs to Herceptin

<p><a href="http://news.yahoo.com/roche-bans-rivals-comparing-copycat-drugs-herceptin-164108256--sector.html"><img src="http://l.yimg.com/bt/api/res/1.2/gZFZBfTYcVYc.Rg8g3_Uqw--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9NzU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2014-02-07T164108Z_1_CBREA161ACR00_RTROPTP_2_ROCHE-RESULTS.JPG" width="130" height="86" alt="The logo of Swiss pharmaceutical company Roche is seen outside their headquarters in Basel" align="left" title="The logo of Swiss pharmaceutical company Roche is seen outside their headquarters in Basel" border="0" /></a>Pharmaceutical group Roche said it secured an injunction from an Indian court banning generic drug makers Biocon and Mylan from comparing their copycat versions of Roche's Herceptin breast cancer treatment to the original. Mylan and Biocon, which co-developed breast cancer drugs CANMab and Hertraz they say are biosimilars of Herceptin, are no longer allowed to refer to Herceptin or its manufacturing process, safety, efficacy and sales when communicating about their drugs, the New Delhi High Court ruled on Wednesday.</p><br clear="all"/>

Source: You are not allowed to view links. Register or Login
You are not allowed to view links. Register or Login